U.S. Tech Hardware Stock News

Why Axalta Coating Systems Is On Investors’ Radar Today Axalta Coating Systems (AXTA) has drawn investor attention after recent trading left the stock with mixed short term returns, including a 0.6% decline over the past day and 3.1% over the past week. See our latest analysis for Axalta Coating Systems. That recent 3.1% 7 day share price decline and 1.9% 30 day share price pullback sit against a 10.9% 90 day share price gain, while the 1 year total shareholder return of 7.7% decline...

Qnity Electronics (NYSE:Q) is pursuing an active M&A pipeline to expand its portfolio following recent strong financial results. The company recently announced a $500 million share repurchase program alongside ongoing product development. The combination of buybacks, new products and targeted acquisitions marks a meaningful shift in how Qnity Electronics is using its balance sheet. For shareholders watching Qnity Electronics at a current share price of $126.76, this new focus on M&A sits on...

Humana stock performance snapshot Humana (HUM) has seen mixed share performance recently, with the stock down over the past month and past 3 months, and also negative on a 1 year and longer term total return basis. At a last close of US$190.54, the health insurer and senior care provider reports annual revenue of about US$129.7b and net income of US$1.19b. See our latest analysis for Humana. Humana's share price has seen a modest 1 day gain and a slight 7 day rise, but these moves sit against...

Recursion Pharmaceuticals reported its first positive clinical proof-of-concept for REC-4881 in familial adenomatous polyposis. The company hit a fifth collaboration milestone with Sanofi tied to its AI driven drug discovery platform. Management extended the cash runway into early 2028, reinforcing funding visibility for ongoing programs. For investors watching NasdaqGS:RXRX, this mix of clinical and partnership progress comes alongside a share price of $3.67 and a 1-year return...

Alpha Metallurgical Resources (AMR) has wrapped up FY 2025 with fourth quarter revenue of US$520.5 million and a basic EPS loss of US$1.34, while trailing twelve month figures show revenue of about US$2.1 billion and a basic EPS loss of US$4.75. Over the past few quarters, revenue has moved from US$617.3 million in Q4 2024 to US$520.5 million in Q4 2025, with quarterly EPS shifting from a loss of US$0.16 in Q4 2024 to a loss of US$1.34 in Q4 2025. Investors may weigh the recent margin trends...

Cinemark Holdings has already reported fourth-quarter 2025 results showing revenue of US$776.3 million and net income of US$34.1 million, alongside full-year 2025 revenue of US$3.12 billion and net income of US$138.2 million. Despite lower quarterly earnings than the prior year, Cinemark’s board maintained a US$0.09 quarterly dividend and completed a US$75 million share repurchase of 3,136,810 shares, signaling continued capital returns. We’ll now examine how Cinemark’s latest earnings...

How Extreme Networks stock has been performing Extreme Networks (EXTR) has drawn attention after a period of weaker share performance, with the stock showing a 7% decline over the past month and a 20.1% decline over the past 3 months. Over a longer horizon, the shares show a 15.5% decline year to date and a 9.5% decline over the past year, alongside a 3 year total return decline of 22.9% and a 5 year total return of 71.3%. For context, the company recently reported annual revenue of US$1.22b...

Why Distribution Solutions Group Is On Watch Today Distribution Solutions Group (DSGR) is back on investor radars after recent share price moves, with the stock closing at $29.92 and showing mixed returns over the past week, month, and past 3 months. See our latest analysis for Distribution Solutions Group. Looking beyond the latest close at $29.92, Distribution Solutions Group has seen a 6.78% 1 month share price return and a 6.70% year to date share price return. The 3 year total...

If you are wondering whether Seagate Technology Holdings is still reasonably priced after its run in the spotlight, you are in the right place to get a clear view of what you might be paying for. The stock last closed at US$407.84, with a 0.8% decline over the past 7 days and a 7.9% decline over the past 30 days, while showing a 41.8% return year to date and a 1 year return of 308%, and 3 and 5 year returns that are also very large. Recent coverage around Seagate has focused on its role in...

In February 2026, SS&C Technologies Holdings, Inc. launched a generative AI-powered sales enablement solution with Thornburg Investment Management, integrated into CRM platforms to aggregate and summarize financial advisor insights, while also affirming a US$0.27 quarterly dividend, introducing the ALPS Nautilus SMR, Nuclear & Technology ETF, and completing onboarding for Australia's REI Super. Taken together, these AI-driven tools, thematic ETF launch and new superannuation mandate...

Danaher (NYSE:DHR) has agreed to acquire Masimo Corporation in a cash and stock deal valued at $9.9b. Masimo, a specialty diagnostics leader, will operate as a standalone business within Danaher’s Diagnostics segment. The transaction is intended to expand Danaher’s presence in healthcare technology and diagnostic solutions. Danaher, trading at around $209.94 per share, is pursuing one of its largest deals as it looks to deepen its role in diagnostics. The stock is up 1.7% over the past year...

Smart Sand (SND) has wrapped up FY 2025 with fourth quarter revenue of US$86.0 million, basic EPS of US$0.03 and net income of US$1.2 million, setting the stage for investors to reassess how the business is converting its top line into profits. Over the past few quarters, the company has seen revenue move between US$65.6 million and US$92.8 million per quarter, while basic EPS has ranged from a loss of US$0.62 to a profit of US$0.55, giving a wide view of how earnings have tracked against...

If you are wondering whether Primerica’s share price reflects its underlying value, this article walks through what the current numbers can and cannot tell you about the stock. Over shorter periods the picture has been mixed, with returns of a 2.9% decline over 7 days, a 2.2% decline over 30 days, a 2.0% decline year to date and an 11.1% decline over 1 year, set against longer term returns of 40.7% over 3 years and 86.8% over 5 years. Recent news coverage has largely focused on Primerica’s...

TTEC Holdings (TTEC) closed out FY 2025 with fourth quarter revenue of US$570 million and a basic EPS loss of US$3.55, alongside a net loss of US$172 million, setting a challenging tone around profitability. Over the last six reported quarters, revenue has moved in a tight band between US$513 million and US$570 million, while quarterly EPS has swung from a small profit of US$0.03 in early 2025 to losses. On a trailing twelve month view, EPS sits at a loss of US$3.99 on revenue of about US$2.1...

If you are wondering whether Paycom Software's current share price lines up with its underlying worth, this breakdown will help you size up what you are really paying for. The stock last closed at US$125.83, with returns of 9.7% over 7 days but declines of 9.9% over 30 days, 17.4% year to date and 42.3% over 1 year, which may have changed how investors view both its potential and its risks. Recent coverage has focused on Paycom's position in the payroll and HR software space, including...

Organon (OGN) is back on investors radar after releasing detailed sub analysis data from its Phase 3 ADORING trials, which showed that VTAMA cream improved sleep outcomes in children with atopic dermatitis and their families. See our latest analysis for Organon. Despite the encouraging VTAMA data, Organon’s recent share price performance has been weak, with a 30 day share price return of negative 18.0% and a 1 year total shareholder return decline of 50.6%, suggesting sentiment remains...

CoreWeave (CRWV) FY 2025 results: rapid top line expansion alongside ongoing losses CoreWeave (CRWV) has just posted its FY 2025 numbers, with fourth quarter revenue of US$1.6b and a basic EPS loss of US$0.83, alongside trailing twelve month revenue of US$5.1b and a loss of US$2.68 per share. Over the past six reported quarters, the company has seen revenue move from US$583.9m in Q3 2024 to US$1.6b in Q4 2025. Quarterly basic EPS has ranged from a loss of US$1.82 in Q3 2024 to a loss of...

Alliant Energy (LNT) is back in focus after multiple research firms updated their views following the company’s fourth quarter and full year 2025 earnings, its reaffirmed 2026 guidance, and progress on large customer projects. See our latest analysis for Alliant Energy. The recent earnings release and reaffirmed 2026 guidance appear to have supported a stronger tone in the stock, with a 9.2% 1 month share price return and a 10.3% year to date share price return sitting alongside a 15.7% 1...

International Paper has already decided to permanently close its Georgetown, South Carolina container plant by year-end 2026, after earlier shutting its local pulp and paper mill and selling its global cellulose fibers business, while also facing higher natural-gas costs from recent winter storms. At the same time, the company is preparing to split into two independent regional businesses, North America and EMEA, shifting away from global packaging deals toward a leaner, region-focused...

Personalis (PSNL) just posted its FY 2025 figures with Q4 revenue of about US$17.3 million and a basic EPS loss of roughly US$0.26, alongside a trailing twelve month EPS loss of about US$0.91 on revenue of roughly US$69.6 million. Over recent quarters, the company has seen quarterly revenue move between about US$14.5 million and US$20.6 million, while quarterly basic EPS losses have ranged from roughly US$0.18 to US$0.26. This keeps the focus squarely on when scale can start to ease those...

Biogen is advancing its Alzheimer’s treatment pipeline, with mid year clinical results for its BIIB080 drug candidate expected in the coming months. The company is also progressing other neurology programs, including felzartamab and the early Alzheimer’s therapy Leqembi. Investors are watching these developments closely as the outcomes could influence sentiment on NasdaqGS:BIIB. Biogen, trading on NasdaqGS:BIIB, last closed at $191.8. The stock is up 9.7% over the past 30 days, 7.9% year to...

Via Transportation (VIA) FY 2025 earnings recap Via Transportation (VIA) just closed out FY 2025 with Q4 revenue of US$118.9 million and a basic EPS loss of US$0.28, while trailing twelve month revenue reached US$434.3 million against a full year EPS loss of US$1.21. The company has seen quarterly revenue move from US$83.3 million in Q3 2024 to US$118.9 million in Q4 2025, as basic EPS ranged between a loss of US$1.70 and US$0.28 over the same stretch, and over the last year management...

Puma Biotechnology (PBYI) closed FY 2025 with Q4 revenue of US$75.5 million and basic EPS of US$0.27, alongside net income of US$13.4 million. Its trailing 12 month revenue came in at US$228.4 million with basic EPS of US$0.62 and net income of US$31.1 million. Over recent periods, the company has seen quarterly revenue range from US$46.0 million to US$80.5 million and basic EPS move between US$0.06 and US$0.98. This gives investors a clear view of how earnings scale with top line...

Emergent BioSolutions (EBS) has just wrapped up FY 2025 with Q4 revenue of US$148.7 million and basic EPS of a US$1.04 loss, capping a year in which quarterly revenue ranged from US$140.9 million to US$231.1 million and EPS swung between a profit of US$1.25 and a loss of US$0.22. Over the trailing 12 months to Q4 2025, the company recorded total revenue of US$742.9 million and basic EPS of US$0.98. This leaves investors to weigh improving headline profitability alongside still uneven...